Insulet Names New CEO, Expects to Top Revenue Projections
1. Ashley McEvoy replaces Jim Hollingshead as Insulet's CEO. 2. Insulet plans to exceed previous revenue estimates for Q1 and full year. 3. Shares dipped slightly despite optimistic revenue guidance ahead of earnings report. 4. Company forecasts 22%-25% revenue growth for Q1 and 16%-20% for the year. 5. Leadership change comes at a crucial time for Insulet's MedTech strategy.